Inventor · disambiguated record
Panliang Gao
Also filed as: GAO PANLIANG
3 granted patents·9 pending applications·74 citations·filing 2017–2024
71Inventor score
Files withJACOBIO PHARMACEUTICALS CO LTD12
Top patents by PatentIndex Score
12 records- 0193US10988466B2Heterocyclic derivatives useful as SHP2 inhibitorsJACOBIO PHARMACEUTICALS CO LTD·Filed 2018·Granted Apr 27, 2021·37 cites·2 claims
- 0293US10858359B2Heterocyclic ring derivatives useful as SHP2 inhibitorsJACOBIO PHARMACEUTICALS CO LTD·Filed 2017·Granted Dec 8, 2020·37 cites·2 claims
- 0375US12233062B2Heterocyclic derivatives useful as SHP2 inhibitorsJACOBIO PHARMACEUTICALS CO LTD·Filed 2024·Granted Feb 25, 2025·0 cites·11 claims
- 0472US2025223285A1Novel heterocyclic derivatives useful as shp2 inhibitorsJACOBIO PHARMACEUTICALS CO LTD·Filed 2024·Application pending·0 cites
- 0560US2024376128A1N-cyclopropylpyrido [4, 3-d] pyrimidin-4-amine derivatives and uses thereofJACOBIO PHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 0659US2025019377A11, 4-oxazepane derivatives and uses thereofJACOBIO PHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 0759US2025034166A1Polycyclic fused ring derivatives and use thereofJACOBIO PHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 0857US2024199644A1Fused Ring Derivatives Useful as KRAS G12D InhibitorsJACOBIO PHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 0955US2024025918A1KRAS G12D InhibitorsJACOBIO PHARMACEUTICALS CO LTD·Filed 2021·Application pending·0 cites
- 1055US2024059710A1KRAS G12D InhibitorsJACOBIO PHARMACEUTICALS CO LTD·Filed 2021·Application pending·0 cites
- 1155US2021393623A1Novel Heterocyclic Derivatives Useful as SHP2 InhibitorsJACOBIO PHARMACEUTICALS CO LTD·Filed 2019·Application pending·0 cites
- 1249US2021040089A1Kras mutant protein inhibitorsJACOBIO PHARMACEUTICALS CO LTD·Filed 2020·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →